STATUTE: 843.15(1)(A)/F
STATUTE: 812.014(2)(A)(1)/F
STATUTE: 831.02/F
STATUTE: 831.09/F
STATUTE: 893.13(6)(A)/F
STATUTE: 893.147(1)(B)/M
STATUTE: 832.05(4)(A)/F
STATUTE: 832.05(4)/M
STATUTE: 832.05(4)/M
STATUTE: 893.13(6)(A)/F
STATUTE: 832.05(4)/M
BOND: $1013
STATUTE: 832.05(4)/M
BOND: $1013
STATUTE: 832.05(4)/M
BOND: $1013
STATUTE: 893.147(1)(B)/M
STATUTE: 812.014(2)(A)/F
STATUTE: 831.02/F
STATUTE: 893.13(6)(A)/F
STATUTE: DRUG9801 (3 F)
NOTES: J/MAYE 8/31/06
STATUTE: DRUG9801 (3 F)
NOTES: J/MAYE 8/31/06
STATUTE: DRUG9801 (3 F)
NOTES: J/MAYE 8/31/06
STATUTE: DRUG9801 (3 F)
BOND: $2000
NOTES: RECOMMIT
STATUTE: DRUG9801 (3 F)
BOND: $2000
NOTES: ALPRAZOLAM
STATUTE: DRUG9801 (3 F)
BOND: $2000
NOTES: OXYCOTIN
STATUTE: DRUG9801 (3 F)
BOND: $2000
NOTES: HYDECODONE
STATUTE: DRUG9801 (3 F)
BOND: $2000
NOTES: CARISPRODOL